Seye Abimbola

University of Sydney, Sydney, New South Wales, Australia

Are you Seye Abimbola?

Claim your profile

Publications (2)3.23 Total impact

  • Article: Health systems in an interconnected world: a view from Nigeria.
    Seye Abimbola
    [show abstract] [hide abstract]
    ABSTRACT: The benefits of an interconnected world for health care remain untapped. As a result of the politics of inequality between rich and poor countries, one or a few health systems are set up as models. Every country, irrespective of political or economic status, should be open to learning from others to build relevant and cost-effective systems. To combat the current global challenge of chronic non-communicable diseases, poor countries have the advantage of flexible health systems that are veritable laboratories of health systems research. Not only can research conducted in these health systems help harness the potential of mobile communication technologies and informal health providers, it can also help rich country health systems adapt to meet the chronic disease challenge.
    MEDICC review 07/2011; 13(3):43-5. · 0.93 Impact Factor
  • Article: The influence of design and definition on the proportion of general epilepsy cohorts with remission and intractability.
    [show abstract] [hide abstract]
    ABSTRACT: Remission while on anti-epileptic drug (AED) therapy and remission off AED are the only prognostic criteria defined by the International League against Epilepsy (ILAE), defining remission as 5 seizure-free years. Prognosis studies in epilepsy have investigated other prognostic categories using different designs and definitions. This systematic review explores factors that explain discrepancies in the proportion of patients reported with commonly studied prognostic categories in general epilepsy cohorts. Thirty publications (reporting 37 studies) were included. The outcome categories were classified as immediate remission (5 studies), remission off medication (7 studies), remission on or off medication (15 studies), intractability (9 studies) and no remission after relapse (1 study). The findings show the importance of qualifying estimates specifically by how they were defined in each study, study design, setting and patient population as these have implications for patient management and counselling. The ILAE should define the outcome measures and terminology to which researchers should be required to adhere in subsequent updates of their guidelines on research related to remission and intractability.
    Neuroepidemiology 01/2011; 36(3):204-12. · 2.31 Impact Factor

Top co-authors

Top Journals

Institutions

  • 2011
    • University of Sydney
      • George Institute for Global Health
      Sydney, New South Wales, Australia
    • National Institute for Pharmaceutical Research and Development, Abuja Nigeria
      Abuja, Nigeria